Updated: Roche buys out CAR-T partner Poseida for $1B upfront

Roche is ac­quir­ing its cell ther­a­py and ge­nom­ic med­i­cines part­ner Po­sei­da Ther­a­peu­tics, the com­pa­nies said Tues­day morn­ing.

The Basel-based phar­ma gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.